Endoscopic Sleeve Gastroplasty Market Size, Production, Sales, Average Product Price, Market Share, Import vs Export 

Technological Advancements Reshaping the Endoscopic Sleeve Gastroplasty Market 

The Endoscopic Sleeve Gastroplasty Market is undergoing a rapid transformation fueled by significant advancements in minimally invasive bariatric procedures. With innovation at the core of modern gastrointestinal therapeutics, the rising adoption of endoscopic suturing systems and enhanced visualization tools has expanded the scope of endoscopic sleeve gastroplasty (ESG). For instance, the integration of AI-assisted navigation in endoscopic equipment has improved precision and reduced procedural time, catalyzing its uptake in outpatient settings. These developments are not only improving patient outcomes but also enabling wider practitioner adoption, contributing to the upward trajectory of the Endoscopic Sleeve Gastroplasty Market. 

Rising Obesity Rates Accelerate Growth in the Endoscopic Sleeve Gastroplasty Market 

One of the most critical drivers of the Endoscopic Sleeve Gastroplasty Market is the global surge in obesity rates. Obesity has become a leading health crisis, with over 650 million adults classified as obese worldwide. As non-surgical interventions often fall short in delivering sustained weight loss, ESG emerges as a powerful alternative. The demand for ESG procedures is particularly surging in regions such as North America and the Middle East, where obesity prevalence exceeds 35% in adult populations. This rise in the obese population directly correlates with increased procedural volumes and hospital investments in endoscopic technologies, pushing the Endoscopic Sleeve Gastroplasty Market toward accelerated growth. 

Preference for Minimally Invasive Procedures Propels the Endoscopic Sleeve Gastroplasty Market 

Patients and healthcare providers are increasingly shifting toward non-invasive and minimally invasive alternatives due to their faster recovery time, reduced complication risk, and cost efficiency. ESG offers these advantages without the need for abdominal incisions or hospitalization, making it a preferred option over traditional bariatric surgery. For example, ESG can be performed in under 90 minutes with most patients discharged the same day. This procedural convenience is a major catalyst for the growth of the Endoscopic Sleeve Gastroplasty Market, especially among younger, working populations seeking quicker return-to-activity options. 

Hospital and Ambulatory Surgical Center Investments Fuel the Endoscopic Sleeve Gastroplasty Market 

Major healthcare systems are ramping up investments in ESG-related infrastructure. Hospitals and ambulatory surgical centers (ASCs) are expanding their endoscopy suites, training staff, and acquiring specialized suturing devices to meet the growing demand. In high-growth markets like India and Brazil, private hospital chains are aggressively adopting ESG to attract urban health-conscious demographics. As a result, the Endoscopic Sleeve Gastroplasty Market is witnessing heightened equipment sales and service revenues across surgical centers, solidifying the foundation for sustained growth. 

Expanding Application of ESG Beyond Weight Loss Amplifies Endoscopic Sleeve Gastroplasty Market Growth 

Beyond weight loss, ESG is gaining clinical relevance in the management of type 2 diabetes, metabolic syndrome, and non-alcoholic fatty liver disease (NAFLD). For instance, clinical studies have demonstrated a 30% improvement in glycemic control post-ESG in obese diabetic patients. These multifaceted benefits are enhancing ESG’s acceptance among endocrinologists and hepatologists, broadening its use beyond bariatric medicine. This multi-specialty integration significantly expands the addressable patient base and strengthens the growth outlook of the Endoscopic Sleeve Gastroplasty Market. 

Surge in Medical Tourism Expands the Global Endoscopic Sleeve Gastroplasty Market 

Countries like Mexico, Turkey, and Thailand are witnessing a surge in medical tourism for ESG procedures due to cost advantages and availability of experienced professionals. Patients from North America and Western Europe are increasingly traveling abroad to access ESG at nearly half the domestic cost. This trend is stimulating ESG procedure volumes in developing nations and encouraging investment in endoscopic innovation. Consequently, the Endoscopic Sleeve Gastroplasty Market is seeing accelerated globalization and competitive pricing, reshaping the value proposition for providers and patients alike. 

Increasing Awareness and Early Adoption Drive the Endoscopic Sleeve Gastroplasty Market 

Healthcare marketing campaigns, digital health platforms, and physician education programs are improving public awareness of ESG. For instance, targeted outreach by gastrointestinal societies and wellness influencers is accelerating ESG’s visibility among eligible patients. Educational webinars and simulation-based ESG training are simultaneously increasing procedural confidence among endoscopists. This synergy of patient education and clinical training is creating a fertile ground for early adoption and wider procedural penetration, further bolstering the Endoscopic Sleeve Gastroplasty Market. 

Favorable Regulatory Approvals Strengthen the Endoscopic Sleeve Gastroplasty Market 

The regulatory landscape is increasingly supportive of ESG technologies. For example, specialized ESG devices have secured market entry through fast-track approvals and favorable reclassification policies in the United States and European Union. These streamlined regulatory pathways are lowering the market-entry barriers for device manufacturers and accelerating innovation cycles. As more devices receive approvals and insurance coverage expands, the Endoscopic Sleeve Gastroplasty Market is expected to witness a broader commercial footprint across emerging and developed regions. 

Competitive Landscape Enhancing Innovation in the Endoscopic Sleeve Gastroplasty Market 

Leading players in the Endoscopic Sleeve Gastroplasty Market are investing aggressively in R&D to maintain their competitive edge. Companies are introducing next-generation suturing systems with enhanced maneuverability and automated features. For instance, devices with 360-degree articulation and haptic feedback are allowing for more efficient tissue manipulation, reducing procedure times. This wave of product differentiation and patent activity is driving innovation while simultaneously raising the technological barrier for new entrants, strengthening the structural integrity of the Endoscopic Sleeve Gastroplasty Market. 

Surge in Insurance Coverage Expands the Endoscopic Sleeve Gastroplasty Market Size 

Insurance providers are gradually including ESG in their reimbursement portfolios, particularly in high-income nations. As of recent years, multiple U.S.-based insurers have started reimbursing ESG for patients with BMI thresholds lower than previously required for surgical bariatric interventions. This development is expanding the insured population eligible for ESG and incentivizing more individuals to opt for the procedure. Consequently, the Endoscopic Sleeve Gastroplasty Market Size is scaling rapidly as insurance support becomes a major enabler of demand. 

Strategic Collaborations and M&A Bolster the Endoscopic Sleeve Gastroplasty Market 

Strategic alliances between hospitals, device manufacturers, and research institutions are shaping the evolution of the Endoscopic Sleeve Gastroplasty Market. Partnerships for clinical trials, device distribution, and procedural training are accelerating technology diffusion and standardization. For example, collaborations focused on ESG procedure accreditation and center-of-excellence programs are improving treatment consistency across geographies. These strategic moves are ensuring a harmonized growth path and unlocking synergistic value across the ESG ecosystem. 

Regional Disparities and Emerging Hubs in the Endoscopic Sleeve Gastroplasty Market 

While North America continues to lead the Endoscopic Sleeve Gastroplasty Market, Asia-Pacific and Latin America are rapidly emerging as growth hubs. For instance, ESG procedure volumes in India and China are growing at over 18 percent CAGR, driven by urbanization, lifestyle changes, and rising obesity rates. Middle Eastern countries are also investing in ESG as part of national obesity control programs. These regional shifts are diversifying the global market dynamics and presenting new opportunities for device manufacturers and healthcare providers alike. 

Future Outlook of the Endoscopic Sleeve Gastroplasty Market 

The Endoscopic Sleeve Gastroplasty Market is expected to maintain its upward trajectory through a combination of technological, demographic, and clinical forces. As the global health burden of obesity and metabolic disorders intensifies, ESG will likely become a mainstream therapeutic solution rather than a niche intervention. By 2030, procedural volumes are projected to double, supported by the expanding Endoscopic Sleeve Gastroplasty Market Size and ongoing advancements in device ergonomics and patient management protocols. 

“Track Country-wise Endoscopic Sleeve Gastroplasty Production and Demand through our Database”

Endoscopic Sleeve Gastroplasty sales volume database for 27+ countries worldwide

 

North America Dominates the Endoscopic Sleeve Gastroplasty Market with Technological Edge 

North America continues to lead the Endoscopic Sleeve Gastroplasty Market, backed by early adoption of advanced gastrointestinal procedures and high healthcare expenditure. The United States accounts for the largest procedural volume, driven by the escalating obesity prevalence, which currently impacts over 40 percent of the adult population. Major metropolitan areas such as Los Angeles, Houston, and New York are witnessing high patient inflow for ESG procedures, especially in outpatient surgery centers. In addition, favorable insurance frameworks and access to cutting-edge endoscopic platforms further solidify North America’s dominance in the Endoscopic Sleeve Gastroplasty Market. 

Europe Shows Steady Expansion in the Endoscopic Sleeve Gastroplasty Market 

Western Europe has shown a consistent rise in ESG procedures, with countries such as Germany, France, and the United Kingdom witnessing increasing hospital procurement of ESG devices. Datavagyanik notes that regulatory approvals under the MDR framework have improved market access for advanced endoscopic suturing tools in these regions. For instance, demand is growing across private hospitals in Spain and Italy, where ESG is becoming an attractive alternative for younger patients seeking less invasive solutions. Public health campaigns around obesity and funding for minimally invasive procedures are expanding the Endoscopic Sleeve Gastroplasty Market across Europe, particularly in urban medical hubs. 

Asia-Pacific Emerging as a High-Growth Region in the Endoscopic Sleeve Gastroplasty Market 

Asia-Pacific is emerging as a critical growth engine for the Endoscopic Sleeve Gastroplasty Market. Rising middle-class income, increasing urbanization, and shifting dietary habits have led to an obesity boom across countries like India, China, and Indonesia. For example, in India alone, the obese population has crossed 135 million, and private hospitals are aggressively marketing ESG as a safer, cost-effective weight-loss solution. Datavagyanik observes that ESG procedural growth in Asia-Pacific is clocking a compound annual growth rate (CAGR) of over 20 percent. Moreover, governments in countries such as South Korea and Singapore are offering incentives for technology transfer and local device manufacturing, further enhancing the market’s depth. 

Middle East and Latin America Strengthen Regional Contributions to the Endoscopic Sleeve Gastroplasty Market 

In the Middle East, countries like the UAE and Saudi Arabia are experiencing a sharp rise in ESG adoption as part of national strategies to reduce chronic disease burden. With over 70 percent of adults in some Gulf countries classified as overweight or obese, the Endoscopic Sleeve Gastroplasty Market is gaining traction in both public and private healthcare sectors. Similarly, Latin America is becoming a hotspot for ESG procedures due to the affordability of care and the popularity of medical tourism. Clinics in Mexico and Brazil are seeing rising ESG volumes from both domestic and international patients, adding momentum to regional market growth. 

Regional Manufacturing Drives Localization in the Endoscopic Sleeve Gastroplasty Market 

Endoscopic Sleeve Gastroplasty Manufacturing is gradually shifting from being U.S.-centric to globally diversified. Countries such as Germany, Japan, and China are increasing local production capacities to reduce dependence on imports and improve supply chain resilience. For example, manufacturers in South Korea have begun producing high-precision suturing devices designed specifically for ESG, catering to the local and Southeast Asian markets. Datavagyanik emphasizes that regional manufacturing hubs are playing a critical role in reducing procurement costs and ensuring device availability for hospitals in tier-2 and tier-3 cities. This trend is expected to decentralize Endoscopic Sleeve Gastroplasty Manufacturing and support regional growth. 

Global Manufacturers Expand Footprint in the Endoscopic Sleeve Gastroplasty Market 

Major players involved in Endoscopic Sleeve Gastroplasty Manufacturing are investing in regional assembly and distribution centers to meet escalating demand. Multinational companies are setting up manufacturing units in Eastern Europe, Southeast Asia, and Latin America to tap into lower labor costs and favorable tax policies. For instance, joint ventures in Malaysia and Brazil are increasing production volumes of ESG-compatible endoscopic platforms. These decentralized production strategies are not only helping to control pricing but also speeding up delivery timelines for hospitals and ambulatory surgical centers across emerging markets, thereby expanding the overall Endoscopic Sleeve Gastroplasty Market. 

Market Segmentation Based on Procedure Type in the Endoscopic Sleeve Gastroplasty Market 

The Endoscopic Sleeve Gastroplasty Market can be segmented by procedure type into primary weight loss procedures and revision procedures. Primary procedures dominate the segment, as patients increasingly opt for ESG over invasive surgeries such as sleeve gastrectomy and gastric bypass. Datavagyanik estimates that primary ESG procedures account for over 75 percent of the total market share. However, the revision procedure segment is growing at a faster pace, especially in the United States and Europe, where patients who have regained weight post-surgery are choosing ESG as a secondary intervention. This dual segmentation is creating new revenue streams for both device manufacturers and healthcare providers. 

Segmentation by End-User Reinforces Growth in the Endoscopic Sleeve Gastroplasty Market 

Hospitals represent the largest end-user segment in the Endoscopic Sleeve Gastroplasty Market due to better access to capital and high-volume surgical teams. However, ambulatory surgical centers are rapidly gaining ground, especially in urban and semi-urban areas, where outpatient care is more feasible. Datavagyanik highlights that ESG procedure volumes in ASCs have grown by over 30 percent annually in the last three years. The convenience, lower costs, and faster turnaround associated with ASCs are attracting a larger share of young patients seeking elective weight loss options, thus enhancing market penetration in the outpatient care segment. 

Patient Demographics Fuel Demand Across Age Groups in the Endoscopic Sleeve Gastroplasty Market 

The Endoscopic Sleeve Gastroplasty Market is no longer confined to middle-aged or morbidly obese populations. Young adults in the 25–35 age bracket are increasingly opting for ESG due to its cosmetic and preventive health benefits. For instance, lifestyle-driven obesity is prompting early intervention through non-surgical procedures. Women, particularly in metropolitan areas, constitute a significant portion of the ESG patient base due to greater aesthetic awareness and access to preventive care. This demographic diversification is reshaping how providers position ESG and is driving growth across multiple age and BMI segments. 

Price Trends Reflect Accessibility Challenges in the Endoscopic Sleeve Gastroplasty Market 

Pricing in the Endoscopic Sleeve Gastroplasty Market varies significantly across regions and care settings. In North America, the average ESG procedure costs between $8,000 and $13,000, while in Southeast Asia or Latin America, the same procedure is available for as low as $3,500. Datavagyanik notes that high procedural costs in developed markets are largely attributed to the use of premium suturing devices and higher facility charges. However, increasing regional Endoscopic Sleeve Gastroplasty Manufacturing is expected to reduce dependency on imported devices and drive cost efficiency over the next five years. 

Reimbursement Policies Impact Price Sensitivity in the Endoscopic Sleeve Gastroplasty Market 

Limited reimbursement coverage continues to be a constraint for broader ESG adoption in some markets. In the United States, while select insurers have begun to cover ESG under specific conditions, a large percentage of procedures are still out-of-pocket expenses. Conversely, in parts of Europe and the Middle East, public health systems are beginning to subsidize ESG as part of anti-obesity programs. This emerging reimbursement support is influencing procedural volume and pricing structures. Datavagyanik forecasts that improved insurance penetration will create downward pressure on ESG prices and make the procedure accessible to a larger patient base. 

Cost Optimization in Endoscopic Sleeve Gastroplasty Manufacturing Enhances Market Reach 

To address price sensitivity, manufacturers are increasingly focusing on lean production models and modular component design. For example, ESG devices with reusable components are reducing the overall cost-per-procedure for hospitals and clinics. Datavagyanik observes that such innovations in Endoscopic Sleeve Gastroplasty Manufacturing are leading to lower capital requirements for procurement and expanding ESG accessibility in mid-tier healthcare centers. Over time, cost-optimized device ecosystems are expected to disrupt the traditional pricing hierarchy and create a more inclusive Endoscopic Sleeve Gastroplasty Market. 

“Endoscopic Sleeve Gastroplasty Manufacturing Database”

• • • Endoscopic Sleeve Gastroplasty top manufacturers market share for 27+ manufacturers
    • Top 7 manufacturers and top 17 manufacturers of Endoscopic Sleeve Gastroplasty in North America, Europe, Asia Pacific
    • Endoscopic Sleeve Gastroplasty sales dashboard, Endoscopic Sleeve Gastroplasty sales data in excel format

 

Leading Manufacturers in the Endoscopic Sleeve Gastroplasty Market 

Apollo Endosurgery, Inc., Medtronic plc, Johnson & Johnson (via Ethicon), Boston Scientific, Olympus, and B. Braun are identified as the most significant players in the global Endoscopic Sleeve Gastroplasty Market. While some are bariatric specialist firms, others are major endoscopy device conglomerates who have entered the ESG space through targeted product lines or acquisitions. 

Apollo Endosurgery Dominates Specialized ESG Market 

Apollo Endosurgery has emerged as a key name in Endoscopic Sleeve Gastroplasty Market share, thanks to its proprietary Overstitch and Apollo ESG systems. These devices, designed specifically for ESG procedures, have gained FDA de novo clearance and wide clinical adoption. Apollo reports that its Overstitch platform has enabled centers to achieve an average 24 percent total body weight loss at 12 months, with excess weight loss of 75 percent, earning feature recognition in top-tier obesity conferences in 2022. This procedural success has translated into Apollo holding a dominant share of the specialized ESG device segment. Apollo also introduced the REVISE system targeting bariatric revision procedures, expanding its footprint in the Endoscopic Sleeve Gastroplasty Market. 

Medtronic Strengthens ESG Portfolio via Covidien Products 

Medtronic, operating its endoscopy division under Covidien, is a top-five global endoscopy equipment player, commanding around 14 percent market share in general endoscopy devices. The company has leveraged its single-incision laparoscopic surgery and natural orifice transluminal devices to support ESG adoption. While Medtronic’s devices are not ESG-specific products like Apollo’s, their compatibility with tissue-approximation tools positions them as a key contender in the broader Endoscopic Sleeve Gastroplasty Market. 

Johnson & Johnson (Ethicon) Expands ESG Reach 

Johnson & Johnson’s Ethicon Endo-Surgery division is recognized as the number one player in the endomechanical instruments space, holding approximately 21 percent of the global endoscopy device market. Ethicon’s contribution to the Endoscopic Sleeve Gastroplasty Market comes through its suturing and stapling tools used in conjunction with ESG procedures. Notably, Ethicon’s product development pipeline aims to deliver enhanced endoscopic tissue manipulation capabilities, thereby supporting greater surgical control and market penetration. 

Boston Scientific’s Acquisition of Apollo Endosurgery 

Boston Scientific significantly boosted its share in the Endoscopic Sleeve Gastroplasty Market when it announced in November 2022 the acquisition of Apollo Endosurgery. This strategic move brings Apollo’s Overstitch and ESG platforms under Boston Scientific’s broader endoscopy portfolio, positioning Boston Scientific to secure a strong market position in endobariatrics. The acquisition aligns with rising demand for ESG in North America and Europe and helps Boston Scientific capture both device and procedural share in the growing Endoscopic Sleeve Gastroplasty Market. 

Olympus, B. Braun, and Other Endoscopy Giants 

Olympus, commanding around 14 percent of the global endoscopy device market, provides advanced HD visualization systems, narrow-band imaging and compatible suturing platforms. While Olympus products are used across various endoscopic procedures, they are playing an increasingly important supporting role in ESG procedures.

Braun, along with CONMED, Cook Medical, Fujifilm, and Karl Storz, makes up the remaining endoscopy equipment market, collectively capturing over 70 percent of market share. Though not ESG-specific, their tools—ranging from endoscope systems to accessories and documentation—form the backbone for centers that perform ESG, reinforcing their influence in the broader Endoscopic Sleeve Gastroplasty Market.

 

Market Share Breakdown by Manufacturer 

• Apollo Endosurgery / Overstitch & Apollo ESG: Holds the largest share of specialized ESG devices and systems, with strong procedural data backing weight-loss outcomes. 

• Boston Scientific: Gains significant incremental market share via the Apollo acquisition, positioning itself as a provider of both general endoscopy and ESG-specific platforms. 

• Ethicon Endo-Surgery: Commands approximately 21 percent of the general endoscopy device market, supplying essential mechanical suturing technology for ESG procedures. 

• Medtronic (Covidien) and Olympus: Each holds around 14 percent share in the global endoscopy device market; their platforms are increasingly used in practice as support systems to the ESG workflow. 

• Other players (B. Braun, CONMED, Cook Medical, etc.): Collectively capture the remaining share in endoscopy infrastructure that supports ESG adoption worldwide. 

 

Noteworthy Product Lines Across Manufacturers 

• Apollo’s Overstitch platform: A full-thickness suturing system that delivers ESG and bariatric revision results. 

• Apollo’s REVISE system: This combined device enables ESG and transoral outlet reduction, extending appeal to revision patients. 

• Medtronic’s Covidien SILS and NOTES platforms: Enable minimally invasive access compatible with ESG protocols. 

• Ethicon’s suturing and stapling technologies: These tools support procedural precision in tissue apposition during ESG interventions. 

• Olympus’s high-definition and narrow-band imaging systems: Used to optimize visualization during suturing and ensure procedural accuracy. 

• Boston Scientific’s integration strategy: By aligning Apollo systems within its existing endoscopy line, Boston Scientific consolidates ESG device and service applications. 

 

Recent Industry Developments and Market Moves 

• August 2022: Apollo Overstitch ESG is featured in a top-10 paper at the IFSO World Congress, reporting 24 percent body weight loss at 12 months among community clinic patients. 

• FDA De Novo Clearance: The U.S. FDA granted de novo authorization to both Apollo ESG and REVISE systems—enabling first-of-their-kind regulatory approval for ESG devices. 

• November 2022: Boston Scientific announces its acquisition of Apollo Endosurgery, signaling a major consolidation in ESG device manufacturing. 

• June 2025: Microbot Medical’s launch in robotic endovascular systems hints at future adaptation of robotics for endoscopic gastroplasty, signaling next-gen innovation. 

• Early 2025: Amneal Pharmaceuticals announces plans to launch an automatic endoscopic gastroplasty system in Q3 2025, further diversifying the Endoscopic Sleeve Gastroplasty Manufacturing landscape. 

 

“Endoscopic Sleeve Gastroplasty Production Data and Endoscopic Sleeve Gastroplasty Production Trend”

• • • Endoscopic Sleeve Gastroplasty sales database for historical years, 10 years historical data
    • Endoscopic Sleeve Gastroplasty sales data and forecast for next 7 years

 

Key Insights that the Endoscopic Sleeve Gastroplasty Market analysis report presents are:

• Endoscopic Sleeve Gastroplasty Market revenue and demand by countries
• Endoscopic Sleeve Gastroplasty Market production and sales volume by countries
• Break-down of the Endoscopic Sleeve Gastroplasty Market in terms of application areas, target customers and other potential market segments
• Areas that are relatively more potential and are faster growing
• Endoscopic Sleeve Gastroplasty Market competitive scenario, market share analysis
• Endoscopic Sleeve Gastroplasty Market business opportunity analysis

 

 

Global and Country-Wise Endoscopic Sleeve Gastroplasty Market Statistics

• Global and Country-Wise Endoscopic Sleeve Gastroplasty Market size ($Million) and Forecast – (2021 – 2028)
• Global and Country-Wise Endoscopic Sleeve Gastroplasty Market Production Volume and Forecast – (2021 – 2028)
• Global and Country-Wise Endoscopic Sleeve Gastroplasty Market Sales Volume and Forecast – (2021 – 2028)
• Global and Country-Wise Endoscopic Sleeve Gastroplasty Market Business Opportunity Assessment